Generalized anxiety disorder Trials in Baltimore, United States
Conditions / Generalized anxiety disorder / Baltimore, United States
Generalized anxiety disorder has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00413010 | Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). | COMPLETED | PHASE3 |
| NCT06046170 | Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA) | COMPLETED | NA |
| NCT00052078 | Child and Adolescent Anxiety Disorders (CAMS) | COMPLETED | PHASE3 |
| NCT00481325 | Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder | COMPLETED | PHASE2/PHASE3 |
| NCT00235508 | Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder | COMPLETED | PHASE4 |
| NCT01629966 | Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder | COMPLETED | PHASE3 |
| NCT00735267 | A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) | TERMINATED | PHASE3 |
| NCT00616655 | Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects | COMPLETED | PHASE2 |
| NCT00658008 | A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) | TERMINATED | PHASE3 |
| NCT00329446 | Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder | COMPLETED | PHASE3 |